See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
"Muu" projekt MARLA15054
MARLA15054 "Haruldasi haigusi puudutava soovituste, informatsiooni ja andmete rakendamine (1.02.2015−31.01.2018)", Vallo Tillmann, Tartu Ülikool, Arstiteaduskond, Lastekliinik, Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut.
Haruldasi haigusi puudutava soovituste, informatsiooni ja andmete rakendamine
Promoting Implementation of Recommendations on Policy, Information and Data for Rare Diseases
Teadus- ja arendusprojekt
ETIS klassifikaatorAlamvaldkondCERCS klassifikaatorFrascati Manual’i klassifikaatorProtsent
3. Terviseuuringud3.6. RahvatervishoidB680 Rahvatervishoid, epidemioloogia3.3. Terviseteadused (tervishoid, sotsiaalmeditsiin, hügieen, õeteadus, epidemioloogia)100,0
Euroopa Komisjon
01.02.2015−31.01.201826 549,71 EUR
26 549,71 EUR

Haruldasi haigusi puudutava soovituste, informatsiooni ja andmete rakendamine
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition leading to diagnostic delay and inappropriate management including adapted social services, poor health outcomes, social burden, limited knowledge on natural history and pathophysiology leading to an insufficient development of new therapies. The low prevalence and the specificity of RD make that a global, multi-stakeholder approach, intended to gather specific expertise and to build shared strategies is necessary to address these issues. The general objectives of RD-Action are to: ▪ Support the further development and sustainability of the Orphanet database, the biggest global repository of informationon RD ▪ Contribute to solutions to ensure an appropriate codification of RD in health information systems ▪ Continue implementation of the priorities identified in Council Recommendation 2009/C151/02 and the Commission Communication (COM 2008 679) on RD, with a view to ensuring the sustainability of the recommended priority actions andto support the work of the Commission Expert Group on Rare Diseases (CEGRD). This JA will expand and consolidate the achievements of the former JAs on RD supported by the European Commission: theOrphanet JA and the EUCERD JA. More precisely, this proposal has the ambition to help member states to implement the recommended measures adopted or to be adopted by the CEGRD and to produce the data necessary for countries to do so. Interactions between the production of data at the Orphanet database level and the implementation of policy priorities including codification will be strengthened during this JA.RD-Action large geographical coverage is key to success as it will promote the transfer of European recommendations into national policies and the collection of information and concerns from MS to the CEGRD, thus to the European Commission.